Clearside Biomedical
CLSD
CLSD
50 hedge funds and large institutions have $4.38M invested in Clearside Biomedical in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
48% less capital invested
Capital invested by funds: $8.46M → $4.38M (-$4.08M)
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Holders
50
Holding in Top 10
–
Calls
$67K
Puts
$96K
Top Buyers
| 1 | +$481K | |
| 2 | +$360K | |
| 3 | +$122K | |
| 4 |
Goldman Sachs
New York
|
+$119K |
| 5 |
Jane Street
New York
|
+$98K |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$538K | |
| 3 | -$451K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$102K |
| 5 |
VF
Virtu Financial
New York
|
-$95K |